Curis, Inc.
General ticker "CRIS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.6M (TTM average)
Curis, Inc. does not follow the US Stock Market performance with the rate: -10.8%.
Estimated limits based on current volatility of 4.6%: low 1.24$, high 1.36$
Factors to consider:
- Total employees count: 136 as of 2000
- Top business risk factors: Insufficient funding, Labor/talent shortage/retention, Expansion risks, Intellectual property risks, Litigation risks
- Current price 28.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.88$, 6.60$]
- 2025-12-31 to 2026-12-31 estimated range: [1.42$, 4.94$]
Financial Metrics affecting the CRIS estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -198.95 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -14.54 <= 18.93
- Positive: Interest expense per share per price, % of 3.09 <= 3.41
Short-term CRIS quotes
Long-term CRIS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $10.16MM | $10.02MM | $10.91MM |
| Operating Expenses | $63.18MM | $58.35MM | $55.45MM |
| Operating Income | $-53.02MM | $-48.33MM | $-44.54MM |
| Non-Operating Income | $-3.65MM | $0.92MM | $1.15MM |
| Interest Expense | $4.77MM | $2.02MM | $0.61MM |
| R&D Expense | $43.28MM | $39.50MM | $38.56MM |
| Income(Loss) | $-56.67MM | $-47.41MM | $-43.39MM |
| Profit(Loss)* | $-56.67MM | $-47.41MM | $-43.39MM |
| Stockholders Equity | $46.55MM | $19.67MM | $-6.00MM |
| Assets | $108.85MM | $77.28MM | $41.27MM |
| Operating Cash Flow | $-54.34MM | $-38.43MM | $-39.56MM |
| Capital expenditure | $0.42MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $33.02MM | $37.79MM | $29.44MM |
| Financing Cash Flow | $0.87MM | $7.58MM | $3.44MM |
| Earnings Per Share** | $-12.14 | $-8.96 | $-6.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.